PCSA logo

Processa Pharmaceuticals (PCSA) Long Term Liabilities

Annual Total Long Term Liabilities

$66.90 K
-$83.70 K-55.58%

31 December 2023

PCSA Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$2200.00
-$23.40 K-91.41%

30 September 2024

PCSA Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PCSA Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-55.6%-97.5%
3 y3 years-93.7%-99.6%
5 y5 years-96.9%-99.9%

PCSA Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-93.7%+804.0%-99.6%at low
5 y5 years-96.9%+804.0%-99.9%at low
alltimeall time-97.0%-99.9%

Processa Pharmaceuticals Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$2200.00(-91.4%)
June 2024
-
$25.60 K(-49.5%)
Mar 2024
-
$50.70 K(-24.2%)
Dec 2023
$66.90 K(-55.6%)
$66.90 K(-24.7%)
Sept 2023
-
$88.80 K(-18.8%)
June 2023
-
$109.30 K(-15.5%)
Mar 2023
-
$129.40 K(-14.1%)
Dec 2022
$150.60 K(+1935.1%)
$150.60 K(-12.3%)
Sept 2022
-
$171.70 K(+3553.2%)
June 2022
-
$4700.00(-23.0%)
Mar 2022
-
$6100.00(-17.6%)
Dec 2021
$7400.00(-99.3%)
$7400.00(-98.7%)
Sept 2021
-
$590.50 K(-19.7%)
June 2021
-
$735.10 K(-18.9%)
Mar 2021
-
$906.40 K(-14.0%)
Dec 2020
$1.05 M(-37.2%)
$1.05 M(-24.9%)
Sept 2020
-
$1.40 M(-7.7%)
June 2020
-
$1.52 M(-0.7%)
Mar 2020
-
$1.53 M(-8.8%)
Dec 2019
$1.68 M(-21.3%)
$1.68 M(-9.7%)
Sept 2019
-
$1.86 M(-8.0%)
June 2019
-
$2.02 M(-9.4%)
Mar 2019
-
$2.23 M(+4.5%)
Dec 2018
$2.13 M
$2.13 M(-5.8%)
Sept 2018
-
$2.27 M(-8.7%)
DateAnnualQuarterly
June 2018
-
$2.48 M(-10.2%)
Mar 2018
-
$2.76 M(>+9900.0%)
Dec 2017
$10.00 K(>+9900.0%)
$10.00 K(>+9900.0%)
Sept 2017
-
$0.00(0.0%)
June 2017
-
$0.00(0.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sept 2016
-
$0.00(0.0%)
June 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2015
-
$27.50 K(-73.8%)
June 2015
-
$104.90 K(-12.1%)
Mar 2015
-
$119.40 K(-75.8%)
Dec 2014
$494.10 K(+239.6%)
$494.10 K(-75.0%)
Sept 2014
-
$1.97 M(+23.4%)
June 2014
-
$1.60 M(+46.3%)
Mar 2014
-
$1.09 M(+651.5%)
Dec 2013
$145.50 K(-76.0%)
$145.50 K(-6.9%)
Sept 2013
-
$156.20 K(+69.2%)
June 2013
-
$92.30 K(-73.6%)
Mar 2013
-
$349.20 K(-42.4%)
Dec 2012
$606.20 K(-72.4%)
$606.20 K(-45.6%)
Sept 2012
-
$1.11 M
Dec 2011
$2.20 M
-

FAQ

  • What is Processa Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals annual total long term liabilities year-on-year change?
  • What is Processa Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Processa Pharmaceuticals?
  • What is Processa Pharmaceuticals quarterly long term liabilities year-on-year change?

What is Processa Pharmaceuticals annual total long term liabilities?

The current annual total long term liabilities of PCSA is $66.90 K

What is the all time high annual total long term liabilities for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high annual total long term liabilities is $2.20 M

What is Processa Pharmaceuticals annual total long term liabilities year-on-year change?

Over the past year, PCSA annual total long term liabilities has changed by -$83.70 K (-55.58%)

What is Processa Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of PCSA is $2200.00

What is the all time high quarterly long term liabilities for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high quarterly total long term liabilities is $2.76 M

What is Processa Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, PCSA quarterly total long term liabilities has changed by -$86.60 K (-97.52%)